We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+21.81%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$593M
AUM Growth
-$62.3M
Cap. Flow
-$26.5M
Cap. Flow %
-4.47%
Top 10 Hldgs %
74.27%
Holding
76
New
22
Increased
11
Reduced
12
Closed
25

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$30.5M
2
ISRG icon
Intuitive Surgical
ISRG
+$9.09M
3
GKOS icon
Glaukos
GKOS
+$7.06M
4
MGX icon
Metagenomi Therapeutics
MGX
+$5.3M
5
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$3.52M

Top Sells

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$328M
2
QTRX icon
Quanterix
QTRX
+$6.82M
3
ESTA icon
Establishment Labs
ESTA
+$6.28M
4
RCEL icon
Avita Medical
RCEL
+$5.28M
5
PODD icon
Insulet
PODD
+$2.71M

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
26
CALL
Bausch Health
BHC
$2.3B
$4.24M 0.72%
+400,000
New +$3.5M
DXCM icon
27
DexCom
DXCM
$33.8B
$4.16M 0.7%
30,000
+3,843
+15% +$483K
INSP icon
28
PUT
Inspire Medical Systems
INSP
$1.67B
$3.76M 0.63%
+17,500
New +$3.43M
VKTX icon
29
Viking Therapeutics
VKTX
$4.04B
$3.27M 0.55%
+39,868
New +$1.77M
INSP icon
30
CALL
Inspire Medical Systems
INSP
$1.67B
$3.22M 0.54%
15,000
-5,000
-25% -$980K
INSP icon
31
Inspire Medical Systems
INSP
$1.67B
$3.22M 0.54%
15,000
+5,000
+50% +$980K
ELAN icon
32
Elanco Animal Health
ELAN
$10.9B
$3.15M 0.53%
193,250
-36,750
-16% -$575K
SWAV
33
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.86M 0.48%
+8,771
New +$2.15M
ISRG icon
34
CALL
Intuitive Surgical
ISRG
$142B
$2.39M 0.4%
6,000
-29,000
-83% -$11M
RGEN icon
35
Repligen
RGEN
$9.36B
$2.06M 0.35%
+11,225
New +$2.14M
GH icon
36
Guardant Health
GH
$22.1B
$2.06M 0.35%
100,000
+85,000
+567% +$1.82M
CUTR
37
DELISTED
Cutera, Inc.
CUTR
$1.59M 0.27%
1,078,727
+8,233
+0.8% +$21.4K
IMDX
38
Insight Molecular Diagnostics
IMDX
$141M
$1.54M 0.26%
523,928
-63,002
-11% -$195K
TNDM icon
39
Tandem Diabetes Care
TNDM
$1.6B
$1.5M 0.25%
+42,500
New +$1.14M
EW icon
40
Edwards Lifesciences
EW
$53.5B
$1.47M 0.25%
+15,408
New +$1.29M
TXG icon
41
10x Genomics
TXG
$7.52B
$1.43M 0.24%
+38,005
New +$1.67M
INMD icon
42
PUT
InMode
INMD
$873M
$1.33M 0.22%
61,600
-113,400
-65% -$2.54M
BAX icon
43
Baxter International
BAX
$14B
$1.28M 0.22%
+30,000
New +$1.22M
ZIMV
44
DELISTED
ZimVie
ZIMV
$1.21M 0.2%
+73,095
New +$1.3M
TMCI icon
45
Treace Medical Concepts
TMCI
$304M
$1.17M 0.2%
+89,897
New +$1.2M
NSPR icon
46
InspireMD
NSPR
$39.8M
$1.07M 0.18%
450,517
– –
MYGN icon
47
Myriad Genetics
MYGN
$301M
$954K 0.16%
44,725
-5,275
-11% -$113K
RCEL icon
48
Avita Medical
RCEL
$242M
$561K 0.09%
35,000
-326,096
-90% -$5.28M
TALKW
49
DELISTED
Talkspace Inc Warrant
TALKW
$85K 0.01%
378,000
– –
RCKTW icon
50
Rocket Pharmaceuticals Warrant
RCKTW
$256K
$12.9K ﹤0.01%
42,960
– –
1
2
3 4

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Pura Vida Investments held 76 positions worth $593M, down 9.5% from $656M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Pura Vida Investments withdrew a net $26.5M in Q1 2024, closing 25 positions and reducing 12 holdings. Its most notable exit was MedAvail Holdings, Inc. Common Stock, an estimated $328M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 64% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Pura Vida Investments opened a new position in Exact Sciences worth $33.3M.

  • Pura Vida Investments's largest Q1 2024 buy was Exact Sciences: 481,910 shares worth $33.3M.
  • Pura Vida Investments added most to AdvisorShares Pure US Cannabis ETF in Q1 2024, an estimated $3.52M increase.
  • Pura Vida Investments's biggest Q1 2024 reduction was Quanterix, cutting an estimated $6.82M.
  • Pura Vida Investments fully exited MedAvail Holdings, Inc. Common Stock in Q1 2024, selling an estimated $328M.
  • Pura Vida Investments's ten largest holdings make up 74% of its $593M portfolio in Q1 2024.
  • Pura Vida Investments opened 22 new positions and closed 25 in Q1 2024.
  • Pura Vida Investments's portfolio value fell 9.5% quarter-over-quarter to $593M.

Based on Pura Vida Investments's 13F filing for Q1 2024, filed 15 May 2024.